Mao

(redirected from monoamine oxidase)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia, Wikipedia.

Mao

In China, a slang term for jiao, a subdivision of currency equivalent to 1/10 of a yuan.
References in periodicals archive ?
Glucocorticoid and androgen activation of monoamine oxidase A is regulated differently by R1 and Sp1.
Molecular mechanism of the relation of monoamine oxidase B and its inhibitors to Parkinson's disease: possible implications of glial cells.
One characteristic of the neurochemical parameters presently investigated, that is, muscarinic receptors (MRs) and monoamine oxidase activity type-B (MAO-B), is that they are also expressed in easily accessible matrices, for example, blood components, such as lymphocytes and platelets.
Tanaka, "Substrate selectivity of monoamine oxidase A, monoamine oxidase B, diamine oxidase, and semicarbazide-sensitive amine oxidase in COS-1 expression systems," Biological & Pharmaceutical Bulletin, vol.
Abbreviations: AFA, Aphanizomenon flos-aquae; MAAs, mycosporine like aminoacids; MAO-A, monoamine oxidase A; MAO-B, monoamine oxidase B; PC, phycocyanin; PEA, phenylethylamine.
Major Finding: Scans revealed 43% more monoamine oxidase across all brain regions in women during postpartum days 4-6, compared with those in controls.
Recently researchers in Geneva set out to determine whether extracts of Rhodiola radix had any effect on the monoaminergic system, specifically on the monoamine oxidase enzyme systems (MAO A and MAO B).
The gene, a variation of the Monoamine oxidase MAOA), affects levels of brain chemicals dopamine and serotonin which affect behaviour and mood.
Evotec AG (Frankfurt:EVT) (Nasdaq:EVTC), Hamburg, Germany, has announced the results of a Phase II proof-of-concept study investigating the potential of EVT 302, a reversible and highly selective inhibitor of monoamine oxidase B (MAO-B), as an aid to smoking cessation.
Randomized placebo-controlled trials with tricyclic and tetracyclic antidepressants (TCAs), selective serotonin reuptake inhibitors (SSRIs), serotonin and noradrenaline reuptake inhibitors (SNRIs), and monoamine oxidase inhibitors (MAOIs) were analyzed.
One sampling of specific topics turns up metabolic syndrome in drug abuse, brain-derived neurotrophic factor in neuronal survival and behavior-related plasticity, nanodevices for neuro-modulation, and the effect of methylene blue and related redox dyes on monoamine oxidase activity as revealed by rats and frogs.